Literature DB >> 3940902

Systemic complement activation and acute lung injury.

G O Till, P A Ward.   

Abstract

Experimental studies of rats have provided significant evidence that intravascular complement activation after i.v. injection of cobra venom factor (CVF) or thermal injury of skin can result in acute lung injury. This has been determined by morphological changes in lung and increases in lung vascular permeability. Systemic complement activation is associated with an early appearance of C5-derived chemotactic activity in the circulation coincident with the development of transient neutropenia, followed by extensive granulocytosis and sequestration of neutrophils in lung interstitial capillaries. The acute pulmonary injury depends on availability of complement and neutrophils. Depletion of either complement or blood neutrophils before CVF injection or thermal injury will prevent development of lung injury. Interventional studies with catalase, scavengers of hydroxyl radical OH., and iron chelators have revealed that the acute pulmonary injury is related to production of oxygen-derived free radicals by activated neutrophils. OH. appears to be the key mediator involved in the acute lung microvascular injury.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3940902

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  10 in total

1.  Mediators of ischemia-reperfusion injury of rat lung.

Authors:  M J Eppinger; G M Deeb; S F Bolling; P A Ward
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces.

Authors:  Christine T N Pham; Lynne M Mitchell; Jennifer L Huang; Christopher M Lubniewski; Otto F Schall; J Kendall Killgore; Dipanjan Pan; Samuel A Wickline; Gregory M Lanza; Dennis E Hourcade
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

3.  Endotoxin-induced lung inflammation is independent of the complement membrane attack complex.

Authors:  R B Brauer; C Gegenfurtner; B Neumann; M Stadler; C D Heidecke; B Holzmann
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  Sulfidopeptide-leukotriene peptidases in pulmonary edema fluid from patients with the adult respiratory distress syndrome.

Authors:  W D Ratnoff; M A Matthay; M Y Wong; Y Ito; K H Vu; J Wiener-Kronish; E J Goetzl
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

Review 5.  Cellular events in alveolitis and the evolution of pulmonary fibrosis.

Authors:  A Burkhardt; H Cottier
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1989

6.  Biological effects of short-term, high-concentration exposure to methyl isocyanate. V. Morphologic evaluation of rat and guinea pig lungs.

Authors:  E H Fowler; D E Dodd; C M Troup
Journal:  Environ Health Perspect       Date:  1987-06       Impact factor: 9.031

7.  Biological effects of short-term, high-concentration exposure to methyl isocyanate. II. Blood chemistry and hematologic evaluations.

Authors:  C M Troup; D E Dodd; E H Fowler; F R Frank
Journal:  Environ Health Perspect       Date:  1987-06       Impact factor: 9.031

8.  Biological effects of short-term, high-concentration exposure to methyl isocyanate. I. Study objectives and inhalation exposure design.

Authors:  D E Dodd; F R Frank; E H Fowler; C M Troup; R M Milton
Journal:  Environ Health Perspect       Date:  1987-06       Impact factor: 9.031

Review 9.  Viral-bacterial synergistic interaction in respiratory disease.

Authors:  L A Babiuk; M J Lawman; H B Ohmann
Journal:  Adv Virus Res       Date:  1988       Impact factor: 9.937

10.  Pretreatment with atorvastatin ameliorates cobra venom factor-induced acute lung inflammation in mice.

Authors:  Jing Guo; Min Li; Yi Yang; Lin Zhang; Li-Wei Zhang; Qian-Yun Sun
Journal:  BMC Pulm Med       Date:  2020-10-12       Impact factor: 3.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.